In GPO Battles, A Pyrrhic Victory for Suppliers
Small product companies that have until now been shut out of major GPO contracting are declaring victory following the announcements by Novation and Premier of new contracting strategies to satisfy Senate investigations. But the reformed GPOs are likely to be weaker for the new moves, raising the question: is this what suppliers really want?
You may also be interested in...
Public Company Edition: The German mRNA-focused company could raise up to $245m based on its proposed price range, but investor interest could drive the offering’s total higher. Also, Perceptive launches another SPAC, Regeneron sells $2bn in debt and Biohaven secures up to $950m.
Agency commissioner appeals to AMA audience to communicate message that FDA review decisions are based on good science.
The deal is part of Medtronic's ongoing strategy to revive its diabetes business with technology that simplifies insulin delivery.